The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Phenylketonuria (PKU) Market Research Report 2025
Synopsis
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
This report mainly focuses on the treatment for PKU.
The global Phenylketonuria (PKU) market was valued at US$ 1334 million in 2023 and is anticipated to reach US$ 2653.6 million by 2030, witnessing a CAGR of 10.2% during the forecast period 2024-2030.
In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.
This report aims to provide a comprehensive presentation of the global market for Phenylketonuria (PKU), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylketonuria (PKU).
Report Scope
The Phenylketonuria (PKU) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phenylketonuria (PKU) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phenylketonuria (PKU) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Segment by Type
Medications
Supplements
Others
Segment by Application
Household
Hospital
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Phenylketonuria (PKU) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Phenylketonuria (PKU) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
This report mainly focuses on the treatment for PKU.
The global Phenylketonuria (PKU) market was valued at US$ 1334 million in 2023 and is anticipated to reach US$ 2653.6 million by 2030, witnessing a CAGR of 10.2% during the forecast period 2024-2030.
In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.
This report aims to provide a comprehensive presentation of the global market for Phenylketonuria (PKU), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylketonuria (PKU).
Report Scope
The Phenylketonuria (PKU) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phenylketonuria (PKU) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phenylketonuria (PKU) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Segment by Type
Medications
Supplements
Others
Segment by Application
Household
Hospital
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Phenylketonuria (PKU) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Phenylketonuria (PKU) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Phenylketonuria (PKU) Market Overview
1.1 Product Overview and Scope of Phenylketonuria (PKU)
1.2 Phenylketonuria (PKU) Segment by Type
1.2.1 Global Phenylketonuria (PKU) Market Value Comparison by Type (2024-2030)
1.2.2 Medications
1.2.3 Supplements
1.2.4 Others
1.3 Phenylketonuria (PKU) Segment by Application
1.3.1 Global Phenylketonuria (PKU) Market Value by Application: (2024-2030)
1.3.2 Household
1.3.3 Hospital
1.4 Global Phenylketonuria (PKU) Market Size Estimates and Forecasts
1.4.1 Global Phenylketonuria (PKU) Revenue 2019-2030
1.4.2 Global Phenylketonuria (PKU) Sales 2019-2030
1.4.3 Global Phenylketonuria (PKU) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Phenylketonuria (PKU) Market Competition by Manufacturers
2.1 Global Phenylketonuria (PKU) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Phenylketonuria (PKU) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Phenylketonuria (PKU) Average Price by Manufacturers (2019-2024)
2.4 Global Phenylketonuria (PKU) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Phenylketonuria (PKU), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Phenylketonuria (PKU), Product Type & Application
2.7 Phenylketonuria (PKU) Market Competitive Situation and Trends
2.7.1 Phenylketonuria (PKU) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Phenylketonuria (PKU) Players Market Share by Revenue
2.7.3 Global Phenylketonuria (PKU) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Phenylketonuria (PKU) Retrospective Market Scenario by Region
3.1 Global Phenylketonuria (PKU) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Phenylketonuria (PKU) Global Phenylketonuria (PKU) Sales by Region: 2019-2030
3.2.1 Global Phenylketonuria (PKU) Sales by Region: 2019-2024
3.2.2 Global Phenylketonuria (PKU) Sales by Region: 2025-2030
3.3 Global Phenylketonuria (PKU) Global Phenylketonuria (PKU) Revenue by Region: 2019-2030
3.3.1 Global Phenylketonuria (PKU) Revenue by Region: 2019-2024
3.3.2 Global Phenylketonuria (PKU) Revenue by Region: 2025-2030
3.4 North America Phenylketonuria (PKU) Market Facts & Figures by Country
3.4.1 North America Phenylketonuria (PKU) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Phenylketonuria (PKU) Sales by Country (2019-2030)
3.4.3 North America Phenylketonuria (PKU) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Phenylketonuria (PKU) Market Facts & Figures by Country
3.5.1 Europe Phenylketonuria (PKU) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Phenylketonuria (PKU) Sales by Country (2019-2030)
3.5.3 Europe Phenylketonuria (PKU) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Phenylketonuria (PKU) Market Facts & Figures by Country
3.6.1 Asia Pacific Phenylketonuria (PKU) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Phenylketonuria (PKU) Sales by Country (2019-2030)
3.6.3 Asia Pacific Phenylketonuria (PKU) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Phenylketonuria (PKU) Market Facts & Figures by Country
3.7.1 Latin America Phenylketonuria (PKU) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Phenylketonuria (PKU) Sales by Country (2019-2030)
3.7.3 Latin America Phenylketonuria (PKU) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Phenylketonuria (PKU) Market Facts & Figures by Country
3.8.1 Middle East and Africa Phenylketonuria (PKU) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Phenylketonuria (PKU) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Phenylketonuria (PKU) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Phenylketonuria (PKU) Sales by Type (2019-2030)
4.1.1 Global Phenylketonuria (PKU) Sales by Type (2019-2024)
4.1.2 Global Phenylketonuria (PKU) Sales by Type (2025-2030)
4.1.3 Global Phenylketonuria (PKU) Sales Market Share by Type (2019-2030)
4.2 Global Phenylketonuria (PKU) Revenue by Type (2019-2030)
4.2.1 Global Phenylketonuria (PKU) Revenue by Type (2019-2024)
4.2.2 Global Phenylketonuria (PKU) Revenue by Type (2025-2030)
4.2.3 Global Phenylketonuria (PKU) Revenue Market Share by Type (2019-2030)
4.3 Global Phenylketonuria (PKU) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Phenylketonuria (PKU) Sales by Application (2019-2030)
5.1.1 Global Phenylketonuria (PKU) Sales by Application (2019-2024)
5.1.2 Global Phenylketonuria (PKU) Sales by Application (2025-2030)
5.1.3 Global Phenylketonuria (PKU) Sales Market Share by Application (2019-2030)
5.2 Global Phenylketonuria (PKU) Revenue by Application (2019-2030)
5.2.1 Global Phenylketonuria (PKU) Revenue by Application (2019-2024)
5.2.2 Global Phenylketonuria (PKU) Revenue by Application (2025-2030)
5.2.3 Global Phenylketonuria (PKU) Revenue Market Share by Application (2019-2030)
5.3 Global Phenylketonuria (PKU) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biomarin
6.1.1 Biomarin Corporation Information
6.1.2 Biomarin Description and Business Overview
6.1.3 Biomarin Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biomarin Phenylketonuria (PKU) Product Portfolio
6.1.5 Biomarin Recent Developments/Updates
6.2 Mead Johnson
6.2.1 Mead Johnson Corporation Information
6.2.2 Mead Johnson Description and Business Overview
6.2.3 Mead Johnson Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mead Johnson Phenylketonuria (PKU) Product Portfolio
6.2.5 Mead Johnson Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Phenylketonuria (PKU) Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Nutricia
6.4.1 Nutricia Corporation Information
6.4.2 Nutricia Description and Business Overview
6.4.3 Nutricia Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nutricia Phenylketonuria (PKU) Product Portfolio
6.4.5 Nutricia Recent Developments/Updates
6.5 Dr. Schär
6.5.1 Dr. Schär Corporation Information
6.5.2 Dr. Schär Description and Business Overview
6.5.3 Dr. Schär Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dr. Schär Phenylketonuria (PKU) Product Portfolio
6.5.5 Dr. Schär Recent Developments/Updates
6.6 Vitaflo
6.6.1 Vitaflo Corporation Information
6.6.2 Vitaflo Description and Business Overview
6.6.3 Vitaflo Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vitaflo Phenylketonuria (PKU) Product Portfolio
6.6.5 Vitaflo Recent Developments/Updates
6.7 Cambrooke
6.6.1 Cambrooke Corporation Information
6.6.2 Cambrooke Description and Business Overview
6.6.3 Cambrooke Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cambrooke Phenylketonuria (PKU) Product Portfolio
6.7.5 Cambrooke Recent Developments/Updates
6.8 PKU Perspectives
6.8.1 PKU Perspectives Corporation Information
6.8.2 PKU Perspectives Description and Business Overview
6.8.3 PKU Perspectives Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 PKU Perspectives Phenylketonuria (PKU) Product Portfolio
6.8.5 PKU Perspectives Recent Developments/Updates
6.9 Firstplay Dietary
6.9.1 Firstplay Dietary Corporation Information
6.9.2 Firstplay Dietary Description and Business Overview
6.9.3 Firstplay Dietary Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Firstplay Dietary Phenylketonuria (PKU) Product Portfolio
6.9.5 Firstplay Dietary Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Phenylketonuria (PKU) Industry Chain Analysis
7.2 Phenylketonuria (PKU) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Phenylketonuria (PKU) Production Mode & Process
7.4 Phenylketonuria (PKU) Sales and Marketing
7.4.1 Phenylketonuria (PKU) Sales Channels
7.4.2 Phenylketonuria (PKU) Distributors
7.5 Phenylketonuria (PKU) Customers
8 Phenylketonuria (PKU) Market Dynamics
8.1 Phenylketonuria (PKU) Industry Trends
8.2 Phenylketonuria (PKU) Market Drivers
8.3 Phenylketonuria (PKU) Market Challenges
8.4 Phenylketonuria (PKU) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
